Abstract
The use of diffusion MRI improved the accuracy of diagnosis in Creutzfeldt–Jakob disease (CJD) and expanded our knowledge of the changes occurring in the brain during the disease. The aim of this study was to test whether in patients with E200K familial CJD (fCJD) the clinical severity correlates with the disease burden as reflected by the extent of cortical involvement in DWI MRI. Consecutive fCJD patients were examined by a neurologist who performed several tests including the CJD neurological scale (CJD-NS), MiniMental status examination (MMSE), Frontal Assessment Battery (FAB), NIH Stroke Scale (NIHSS), and the expanded disability status scale (EDSS). A simultaneously acquired MRI was analyzed by measuring the extent of cortical involvement in the DWI axial sequence. Correlations were tested for using Pearson test. Fifty-two fCJD patients (35 males, mean age 59.4 ± 5.7 years) were recruited to the study. Significant negative correlation was found between the extent of cortical involvement and the cognitive performance of the patients as reflected by their MMSE and FAB scores. In addition, a significant positive correlation was found between the MRI and the clinical disease severity scales CJD-NS and EDSS. The correlation between clinical scales of severity and cognitive dysfunction and the disease burden confirms the reliability of the CJD-NS scale. Further studies are warranted to examine whether MRI may serve not only for diagnosis but also as a biomarker for follow-up of disease progression and the efficacy of potential treatments.
Similar content being viewed by others
References
Bahn MM, Kido DK, Lin W, Pearlman AL (1997) Brain magnetic resonance diffusion abnormalities in Creutzfeldt–Jakob disease. Arch Neurol 541:411–415
Basser PJ (1995) Inferring microstructural features and the physiological state of tissues from diffusion-weighted images. NMR Biomed 8:333–344
Caverzasi E, Henry RG, Vitali P, Lobach IV, Kornak J, Bastianello S, DeArmond SJ, Miller BI, Rosen HJ, Mandellli MI, Geschwind MD (2014). Application of quantitative DTI metrics in sporadic CJD. NeuroImage Clin 4:426–435
Cohen OS, Hoffmann C, Chapman J, Ephraty L, Prohovnik I (2007) Correlation between DTI and neurological symptoms in patients with fCJD. Neurology (12 suppl 1):A141–168
Cohen OS, Hoffmann C, Lee H, Chapman J, Fulbright RK, Prohovnik I (2009) MRI detection of the cerebellar syndrome in Creutzfeldt–Jakob disease. Cerebellum 8:373–381
Cohen OS, Prohovnik I, Korczyn AD, Ephraty L, Nitsan Z, Tsabari R, Appel S, Rosenmann H, Kahana E, Chapman J (2011) The Creutzfeldt–Jakob disease (CJD) neurological status scale: a new tool for evaluation of disease severity and progression in CJD. Acta Neurol Scand 124:368–374
Cyngiser TA (2008) Creutzfeldt–Jakob disease: a disease overview. Am J Electroneurodiagn Technol 48:199–208
Demaerel P, Baert AL, Vanopdenbosch L, Robberecht W, Dom R (1997) Diffusion-weighted magnetic resonance imaging in Creutzfeldt–Jakob disease. Lancet 349:847–848
Demaerel P, Heiner L, Robberecht W, Sciot R, Wilms G (1999) Diffusion-weighted MRI in sporadic Creutzfeldt–Jakob disease. Neurology 52:205–208
Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55:1621–1626
Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Fulbright RK, Kingsley PB, Guo X, Hoffmann C, Kahana E, Chapman JC, Prohovnik I (2006) The imaging appearance of Creutzfeldt–Jakob disease caused by the E200K mutation. Magn Reson Imaging 24:1121–1129
Fulbright RK, Hoffmann C, Lee H, Pozamantir A, Chapman J, Prohovnik I (2008) MR imaging of familial Creutzfeldt–Jakob disease: a blinded and controlled Study. AJNR Am J Neuroradiol 29:1638–1643
Gao T, Lyu JH, Zhang JT, Lou X, Zhao W, Xing XW, Yang M, Yao Y, Tan QC, Tian CL, Huang XS, Ma L, Yu SY (2015) Diffusion-weighted MRI findings and clinical correlations in sporadic Creutzfeldt–Jakob disease. J Neurol 262(6):1440–1446
Goldfarb LG, Korczyn AD, Brown P, Chapman J, Gajdusek DC (1990) Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt–Jakob disease in Sephardic Jews of Libyan and non-Libyan origin. Lancet 336:637–638
Korczyn AD (1997) Prion diseases. Curr Opin Neurol 10(3):273–281
Kropp S, Schulz-Schaeffer WJ, Finkenstaedt M, Riedemann C, Windl O, Steinhoff BJ, Zerr I, Kretzschmar HA, Poser S (1999) The Heidenhain variant of Creutzfeldt–Jakob disease. Arch Neurol 56(1):55–61
Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452
Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, Haley EC, Grotta J, Marler J (1994) Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke 25:2220–2226
Meiner Z, Kahana E, Baitcher F, Korczyn AD, Chapman J, Cohen OS, Milo R, Aharon-Perez J, Abramsky O, Gabizon R (2011) Tau and 14-3-3 of genetic and sporadic Creutzfeldt–Jakob disease patients in Israel. J Neurol 258:255–262
Meissner B, Körtner K, Bartl M, Jastrow U, Mollenhauer B, Schoter A, Finkenstaedt M, Windl O, Poser S, Kretzschmar HA, Zerr I (2004) Sporadic Creutzfeldt–Jakob disease magnetic resonance imaging and clinical findings. Neurology 63(3):450–456
Na DL, Suh CK, Choi SH, Moon HS, Seo DW, Kim SE, Na DG, Adair JC (1999) Diffusion-weighted magnetic resonance imaging in probable Creutzfeldt–Jakob disease: a clinical–anatomic correlation. Arch Neurol 56(8):951–957
Otto M, Wiltfang J, Cepek L, Neumann M, Mollenhauer B, Steinacker P, Ciesielczyk B, Schulz-Schaeffer W, Kretzschmar HA, Poser S (2002) Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt–Jakob disease. Neurology 58:192–197
Prusiner SB (1991) Molecular biology of prion diseases. Science 252:1515–1522
Russmann H, Vingerhoets F, Miklossy J, Miklossy J, Maeder P, Glatzel M, Aguzzi A, Bogousslavsky J (2005) Sporadic Creutzfeldt–Jakob disease, a comparison of pathological findings and diffusion weighted imaging. J Neurol 252(3):338–342
Urbach H, Klisch J, Wolf HK, Brechtelsbauer D, Gass S, Solymosi L (1998) MRI in sporadic Creutzfeldt–Jakob disease: correlation with clinical and neuropathological data. Neuroradiology 40:65–70
Veselinovic N, Pavlovic AM, Petrovic B, Ristic A, Novakovic I, Medjedovic TS, Pavlovic D, Sternic N (2014) Altered basal ganglia echogenicity early in sporadic Creutzfeldt–Jakob disease. Cognit Behav Neurol 27(1):48–50
WHO (1998) Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of the WHO consultation. In: World health organization: emerging and other communicable diseases, surveillance and control, 9–11 February 1998, Geneva
Young GS, Geschwind MD, Fischbein NJ, Fischbein NJ, Martindale JL, Henry RG, Liu S, Lu Y, Wong S, Liu H, Miller BL, Dillon WP (2005) Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt–Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 26:1551–1562
Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, Breithaupt M, Varges D, Meissner B, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie D, Smith P, Roberts H, Brandel JP, van Duijn C, Pocchiari M, Begue C, Cras P, Will RG, Sanchez-Juan P (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt–Jakob disease. Brain 132:2659–2668
Acknowledgments
The work was partially supported by National Institute of Health (NIH) Grant #NS043488.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Cohen has no conflict of interest. Prof. Chapman has no conflict of interest. Prof. Korczyn has no conflict of interest. Mr. Siaw has no conflict of interest. Mrs. Warman-Alaluf has no conflict of interest. Dr. Nitsan has no conflict of interest. Dr. Appel has no conflict of interest. Prof. Kahana has no conflict of interest. Dr. Rosenmann has no conflict of interest. Dr. Hoffmann has no conflict of interest.
Rights and permissions
About this article
Cite this article
Cohen, O.S., Chapman, J., Korczyn, A.D. et al. Clinical radiological correlation in E200K familial Creutzfeldt–Jakob disease. J Neural Transm 123, 1457–1462 (2016). https://doi.org/10.1007/s00702-016-1617-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-016-1617-3